NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 110 filers reported holding NGM BIOPHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $23,550,000 | -27.9% | 1,194,237 | +6.2% | 6.12% | +3.6% |
| Q1 2021 | $32,682,000 | +7.3% | 1,124,237 | +11.8% | 5.91% | -6.7% |
| Q4 2020 | $30,463,000 | +88.0% | 1,005,534 | -1.3% | 6.33% | +269.2% |
| Q3 2020 | $16,202,000 | -25.1% | 1,018,334 | -7.0% | 1.72% | -60.7% |
| Q2 2020 | $21,619,000 | +67.4% | 1,095,184 | +4.6% | 4.36% | -13.4% |
| Q1 2020 | $12,912,000 | – | 1,047,184 | – | 5.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 3,766,666 | $59,928,000 | 49.90% |
| Greenspring Associates, LLC | 1,573,357 | $25,032,000 | 38.95% |
| Svennilson Peter | 18,017,932 | $286,665,000 | 23.39% |
| Aquilo Capital Management, LLC | 1,018,334 | $16,202,000 | 1.72% |
| Jasper Ridge Partners, L.P. | 308,750 | $4,912,000 | 0.28% |
| Samsara BioCapital, LLC | 36,451 | $580,000 | 0.16% |
| Rock Springs Capital Management LP | 360,454 | $5,735,000 | 0.15% |
| Point72 Asset Management, L.P. | 1,611,850 | $25,645,000 | 0.13% |
| Virtus ETF Advisers LLC | 14,880 | $237,000 | 0.12% |
| WELD CAPITAL MANAGEMENT LLC | 15,238 | $242,000 | 0.10% |